SALL4 is a key transcription regulator in normal human hematopoiesis
- 31 August 2012
- journal article
- hematopoiesis
- Published by Wiley in Transfusion
- Vol. 53 (5), 1037-1049
- https://doi.org/10.1111/j.1537-2995.2012.03888.x
Abstract
BACKGROUND: Stem cell factor SALL4 is a zinc finger transcription factor. It plays vital roles in the maintenance of embryonic stem cell properties, functions as an oncogene in leukemia, and has been recently proposed to use for cord blood expansion. The mechanism(s) by which SALL4 functions in normal human hematopoiesis, including identification of its target genes, still need to be explored. STUDY DESIGN AND METHODS: Chromatin immunoprecipitation followed by microarray hybridization (ChIP‐chip) was used for mapping SALL4 global gene targets in normal primary CD34+ cells. The results were then correlated with SALL4 functional studies in the CD34+ cells. RESULTS: More than 1000 potential SALL4 downstream target genes have been identified, and validation of binding by ChIP‐quantitative polymerase chain reaction was performed for 5% of potential targets. These include genes that are involving in hematopoietic differentiation and self‐renewal, such as HOXA9, RUNX1, CD34, and PTEN. Down regulation of SALL4 expression using small‐hairpin RNA in these cells led to decreased in vitro myeloid colony–forming abilities and impaired in vivo engraftment. Furthermore, HOXA9 was identified to be a major SALL4 target in normal human hematopoiesis and the loss of either SALL4 or HOXA9 expression in CD34+ cells shared a similar phenotype. CONCLUSION: Taken together, SALL4 is a key regulator in normal human hematopoiesis and the mechanism of its function is at least in part through the HOXA9. Future study will determine whether modulating the SALL4/HOXA9 pathway can be used in cellular therapy such as cord blood expansion and/or myeloid engraftment.Keywords
This publication has 38 references indexed in Scilit:
- Enhanced self-renewal of hematopoietic stem/progenitor cells mediated by the stem cell gene Sall4Journal of Hematology & Oncology, 2011
- SALL4 is a robust stimulator for the expansion of hematopoietic stem cellsBlood, 2011
- Dissecting the role of SALL4, a newly identified stem cell factor, in chronic myelogenous leukemiaLeukemia, 2011
- HOXA9 is required for survival in human MLL-rearranged acute leukemiasBlood, 2009
- Genome-wide analysis reveals Sall4 to be a major regulator of pluripotency in murine-embryonic stem cellsProceedings of the National Academy of Sciences, 2008
- SALL4 is a key regulator of survival and apoptosis in human leukemic cellsBlood, 2008
- Bmi-1 is a target gene for SALL4 in hematopoietic and leukemic cellsProceedings of the National Academy of Sciences, 2007
- A Sall4 mutant mouse model useful for studying the role of Sall4 in early embryonic development and organogenesisGenesis, 2007
- Murine inner cell mass-derived lineages depend on Sall4 functionProceedings of the National Academy of Sciences, 2006
- SALL4, a novel oncogene, is constitutively expressed in human acute myeloid leukemia (AML) and induces AML in transgenic miceBlood, 2006